Search clinical trials for: Fibersol-2

Total 47782 results

ModernaTX, Inc.

Terminated

Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study

SARS-CoV-2

United States
Direction Centrale du Service de Santé des Armées

Completed

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling (CoviDiagMS)

SARS-CoV 2

France
ModernaTX, Inc.

Completed

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

SARS-CoV-2

United States
IRCCS San Raffaele Roma

Completed

COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility (COVID-19)

SARS-Cov2

Italy
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaborators

Completed

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

SARS-CoV 2

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

SARS-CoV-2

United States
Fondazione Epatocentro Ticino

Active, not recruiting

Methylene Blue Treatment of COVID-19

SARS-CoV2

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP (FamilyPEDCOVID)

SARS-CoV2

France
Centre Hospitalier Universitaire de Besancon

Completed

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy (TRANSCOVID)

Sars-CoV2

France
Direction Centrale du Service de Santé des Armées

Completed

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) (EpiCovCreil)

Sars-CoV2

France
Centre Hospitalier Universitaire Vaudois

Completed

Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. (RESTART)

SARS-CoV-2

Switzerland
Direction Centrale du Service de Santé des Armées

Completed

Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff (SEROSARSCOV)

Sars-CoV2

France
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
ModernaTX, Inc.

Recruiting

Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.

SARS-CoV-2

Korea, Republic of
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Recruiting

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

SARS-CoV-2

China
Biomad AS

Not yet recruiting

Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

Sars-cov-2

Iraq
SENAI CIMATEC

Recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

SARS-CoV-2

Brazil
S.L.A. Pharma AG

Recruiting

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

SARS-CoV-2

Spain, United Kingdom
ModernaTX, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...

Completed

A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

SARS-CoV-2

United States
ModernaTX, Inc.

Completed

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters

SARS-CoV-2

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

SARS-CoV-2

United States, Dominican Republic
University of Southern California
National Institute on Aging (NIA); AltaMed Health Services Corporation

Completed

Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities

SARS-CoV-2

United States
ModernaTX, Inc.

Completed

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

SARS-CoV-2

United States
ModernaTX, Inc.

Completed

A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

SARS-CoV-2

United Kingdom
Direction Centrale du Service de Santé des Armées

Completed

Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff (IMMUNO-COVID)

Sars-CoV2

France
GlaxoSmithKline
CureVac

Completed

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

SARS-CoV-2

United States
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

SARS-CoV-2

China
Providence Health & Services
OncoSec Medical Incorporated

Completed

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12)

SARS-CoV-2

United States
GeneOne Life Science, Inc.

Active, not recruiting

GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)

SARS-CoV-2

Korea, Republic of
ModernaTX, Inc.

Completed

A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind (disCOVEries)

SARS-CoV-2

United States
Genexine, Inc.

Active, not recruiting

Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

SARS-CoV-2

Korea, Republic of
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Active, not recruiting

CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms (CANDIDATE)

SARS-CoV2

Brazil
I.M. Sechenov First Moscow State Medical University
Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI...

Completed

COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy

SARS-CoV-2

Russian Federation
E25Bio, Inc.
SCRI Development Innovations, LLC

Completed

A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests

SARS CoV-2

United States
Philipps University Marburg Medical Center

Completed

Do Videos That Aim to Optimize Expectations Alter the Effectivess of PMR?

Control Group | Experimental Group 1 (Video Personal Expert) | Experimental Group 2 (Video Factual Expert)

Germany
ContraFect

Completed

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

Staphylococcus Aureus Bacteremia | Staphylococcus Aureus Endocarditis

United States, Belgium, Bulgaria, Chile, Czechia, France, Germany, Greece, Guatemala, Israel, Italy, Russian Federation, Spain, United Kingdom
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Recruiting

Testing a New Imaging Agent to Identify Cancer

HER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of Breast

United States
University of Kansas Medical Center
National Institute on Aging (NIA)

Completed

Dementia Risk and Dynamic Response to Exercise (DYNAMIC)

Healthy Aging | Alzheimer Disease 2 Due to Apoe4 Isoform

United States
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC (LungCadX)

NSCLC

China
Johannes Gutenberg University Mainz

Recruiting

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry (MICAT)

Coronary Artery Disease | Microvascular Dysfunction

Germany
Novartis Pharmaceuticals

Completed

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg (EXPLOR)

Hypertension

France
Gerencia De Atencion Primaria Area 2 De Madrid
Health Research Fund of ISCIII Spain

Completed

Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

Cardiovascular Risk Factors | Primary Care | Clinical Practice Guideline | Implementation Strategies

Spain
Eisai Inc.
Merck Sharp & Dohme LLC

Completed

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Thyroid Cancer

United States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
Universidad de la Republica
Hospital Italiano de Buenos Aires; KU Leuven

Withdrawn

Telemonitoring of Uncontrolled Hypertension (ERNESTINA)

Hypertension

Argentina, Uruguay
Chong Kun Dang Pharmaceutical

Completed

CKD-828 (80/5mg) Pharmacokinetic Study (CKD-828)

Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-828 (80/5mg) Pharmacokinetic Study

Hypertension

Korea, Republic of
Kyorin University

Completed

MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy

MicroRNA Expression Profile in Human Vitreous of Various Vitreoretinal Diseases

Japan
Air Liquide SA
Inamed

Completed

Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease

Healthy | Chronic Obstructive Pulmonary Disease | Asthma

Germany
Morphic Therapeutic, Inc

Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)

Inflammatory Bowel Diseases | Crohn's Disease

United States, Georgia
Hebei Senlang Biotechnology Inc., Ltd.

Recruiting

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Adult B Acute Lymphoblastic Leukemia

China

Search clinical trials for: Fibersol-2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations